SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that an indirectly wholly-owned subsidiary of the Company, Cuprina Pte. Ltd. has received 510(k) clearance from the U.S. […]
Category Archives: People
Fans Can Score a Beer Rebate When Tournament Underdogs Shock the World ATLANTA, June 15, 2026 (GLOBE NEWSWIRE) — Shock Top, the bold and refreshing Belgian-style wheat ale from Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), is bringing ‘Shocking Upsets’ to the world’s biggest summer of soccer, the fan-favorite promotion that rewards consumers when tournament […]
Anadarko Basin project pairs continued American oil production with permanent CO₂ storage — Blue Energy’s first U.S. operation and the foundation of a new Carbon-Neutral Division MEXICO CITY & OKLAHOMA CITY, Okla., June 15, 2026 (GLOBE NEWSWIRE) — Blue Energy, power supplier and renewable-energy platform owned by EIM Capital, today announced that it has entered […]
OCALA, Fla., June 15, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM,” or the “Company”), an immuno-pharma company focused on the development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, today announced that it has received written notice from the NYSE American that AIM has regained compliance […]
Navacaprant did not achieve the primary endpoint in KOASTAL-2 or -3; Company to discontinue development of navacaprant Advancing potential best-in-class programs with NMRA-511 in Alzheimer’s disease agitation, NMRA-898 in schizophrenia and NMRA-215 in cardiometabolic disease Aligning organization to support initiation of multiple clinical studies, with cash runway into the third quarter of 2027 WATERTOWN, Mass., […]
ALISO VIEJO, Calif., June 15, 2026 (GLOBE NEWSWIRE) — SpyGlass Pharma, Inc. (Nasdaq: SGP) (SpyGlass Pharma or Company), a late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel. Ms. Treviño brings significant business-oriented legal experience and leadership that results in operating excellence for publicly traded companies at various stages of growth. […]
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) — Porosome Therapeutics, Inc., announced today that it has entered into a drug development partnership with the Council of Scientific and Industrial Research (CSIR) of the Government of India, the premier scientific research and development organization in the country. CSIR announced that its “partnership with Porosome Therapeutics reflects CSIR’s […]
AMSTERDAM, June 15, 2026 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSH) is bringing a practical provider-transformation message during its participation at HLTH Europe 2026, taking place in Amsterdam from June 15 to 18: hospitals cannot meet rising demand through technology alone; they must redesign care pathways, use real-time data, and build […]
Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies ROCKVILLE, Md. and SUZHOU, China, June 14, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies […]
ZW191 demonstrates compelling anti-tumor activity in platinum-resistant ovarian cancer patients regardless of FRα expression level Confirmed objective response rate (cORR) of 78.6% in FRα-positive (≥75% at PS2+) platinum-resistant ovarian cancer patients and 47.4% in FRα-negative patients (<75% at PS2+) across all dose levels studied Median duration of response was not reached at the time of […]


